June 2017 Vol 3 No 3
By Yelak Biru
Yelak Biru, who was diagnosed with multiple myeloma at age 25, shares his inspiring story, including the top 3 lessons that helped him remain positive. Read More ›
By Alisa Lehman
Check out this whimsical and delightful creature created by Alisa Lehman to emphasize the positive side of life while dealing with metastatic breast cancer. Read More ›
Check out the differences between alternative, complementary, and integrative medicine to help you or a loved one navigate through therapy options. Read More ›
“Navigators can play an important role in assisting patients and caregivers in managing diabetes and cancer treatment,” says oncology nurse navigator Cheryl Bellomo. Read More ›
On April 17, 2017, the FDA approved the PD-L1 inhibitor Tecentriq (atezolizumab; from Genentech) for use as first-line treatment for patients with locally advanced or metastatic urothelial carcinoma who cannot use cisplatin chemotherapy. Read More ›
